Literature DB >> 18693161

Hypersensitivity to cyclooxygenase inhibitory drugs in children: a study of 164 cases.

Amale Hassani1, Claude Ponvert, Chantal Karila, Muriel Le Bourgeois, Jacques De Blic, Pierre Scheinmann.   

Abstract

Hypersensitivity to cyclooxygenase (COX) inhibitors is rare in children. We studied 164 children reporting 213 reactions to paracetamol, ibuprofen and/or acetylsalicylic acid (ASA). Most reactions were cutaneous, either isolated or associated with respiratory symptoms and/or anaphylaxis. Based on a convincing clinical history or positive responses in challenges with the drug(s), hypersensitivity to one or several drug(s) was diagnosed in 49.4% of the children (60, 76.5 and 23.2% of the children reporting reactions to ASA, ibuprofen and paracetamol respectively). Cross-reactivity between nonsteroidal anti-inflammatory drugs (NSAIDs) was frequent (69.1%), but only 10.6% of the NSAID-sensitive children reacted to paracetamol. In contrast, all paracetamol-sensitive children reacted to NSAIDs. Anaphylaxis, immediate and accelerated reactions, atopy, older age and chronic/recurrent urticaria were risk factors for hypersensitivity and/or cross-reactivity between ASA, ibuprofen and paracetamol. In conclusion, hypersensitivity to COX inhibitors was frequent, especially in children reporting severe and/or immediate and accelerated reactions, and in older and atopic children. Cross-reactivity was frequent, suggesting that most reactions resulted from a non allergic hypersensitivity linked to the pharmacological properties of the drugs. However, in a few children, the reactions may result from allergic hypersensitivity to selective (families of) drugs, with tolerance to other drugs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18693161     DOI: 10.1684/ejd.2008.0480

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  6 in total

1.  Diagnostic evaluation and risk factors for drug allergies in children: from clinical history to skin and challenge tests.

Authors:  Tugba Arikoglu; Gulen Aslan; Sehra Birgul Batmaz; Gulcin Eskandari; Ilter Helvaci; Semanur Kuyucu
Journal:  Int J Clin Pharm       Date:  2015-03-31

2.  Anaphylaxis to ibuprofen in a 12-year-old boy.

Authors:  Emily Kay; Moshe Ben-Shoshan
Journal:  BMJ Case Rep       Date:  2013-01-14

Review 3.  SIAIP position paper: provocation challenge to antibiotics and non-steroidal anti-inflammatory drugs in children.

Authors:  Carlo Caffarelli; Fabrizio Franceschini; Davide Caimmi; Francesca Mori; Lucia Diaferio; Dora Di Mauro; Carla Mastrorilli; Stefania Arasi; Simona Barni; Paolo Bottau; Silvia Caimmi; Fabio Cardinale; Pasquale Comberiati; Giuseppe Crisafulli; Lucia Liotti; Umberto Pelosi; Francesca Saretta; Gianluigi Marseglia; Marzia Duse; Francesco Paravati
Journal:  Ital J Pediatr       Date:  2018-12-07       Impact factor: 2.638

Review 4.  NSAID Hypersensitivity in the Pediatric Population: Classification and Diagnostic Strategies.

Authors:  Ozlem Cavkaytar; Mustafa Arga
Journal:  J Asthma Allergy       Date:  2022-09-28

5.  Mite-induced inflammation: More than allergy.

Authors:  Mario Sánchez-Borges; Enrique Fernández-Caldas; Arnaldo Capriles-Hulett; Fernan Caballero-Fonseca
Journal:  Allergy Rhinol (Providence)       Date:  2012-05-03

Review 6.  NSAID-induced reactions: classification, prevalence, impact, and management strategies.

Authors:  Natalia Blanca-Lopez; Victor Soriano; Elena Garcia-Martin; Gabriela Canto; Miguel Blanca
Journal:  J Asthma Allergy       Date:  2019-08-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.